Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Food-manufacture

HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6UG
June 02, 2020
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U9
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U5
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U0
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TX
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TW
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QO
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QN
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QL
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QK
June 02, 2020
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate...
Washington, United States of America
Senate Finance Committee
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration FDA), before leaving the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QI
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QB
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q8
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q7
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q2
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PR
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PQ
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PO
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on as Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6P6
June 02, 2020
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food...
Washington, UNITED STATES
Senate Finance Committee
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LC
June 02, 2020
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability...
Washington, United States of America
Senate Finance Committee
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability Office, left, speaks via teleconference as Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LB
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference as United States Senator Todd Young (Republican of Indiana) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L9
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L8
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L0
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KZ
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KY
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KX
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KT
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KR
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KL
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KK
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KH
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KG
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K6
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K3
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JX
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JT
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JS
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JR
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6HS
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G7
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G3
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G2
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6FJ
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6F3
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6F2
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
CLIMATE-CHANGE/MALI
RTX7AOGG
November 27, 2019
Cattle drink water from Lake Wegnia, in Sahel region of Koulikoro, Mali November 23, 2019. Picture taken...
Koulikoro, Mali
Cattle drink water from Lake Wegnia, in Sahel region of Koulikoro
Cattle drink water from Lake Wegnia, in Sahel region of Koulikoro, Mali November 23, 2019. Picture taken November 23, 2019. REUTERS/Arouna Sissoko
USA-SUGAR/
RTX7AODK
November 27, 2019
Sugar beets covered in snow at a processing facility in East Grand Forks, Minnesota, U.S., November 22,...
EAST GRAND FORKS, UNITED STATES
Frozen harvest leaves bitter taste for US sugar beet farmers
Sugar beets covered in snow at a processing facility in East Grand Forks, Minnesota, U.S., November 22, 2019. Due to a wet summer and early frost, sugar beet farmers were forced to leave hundreds of acres of sugar beet crop unharvested, a hard hit for the US agriculture industry already experiencing a difficult few years. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-SUGAR/
RTX7AODG
November 27, 2019
Sugar beets piled in a large storage building, which is typically completely full, in East Grand Forks,...
EAST GRAND FORKS, UNITED STATES
Frozen harvest leaves bitter taste for US sugar beet farmers
Sugar beets piled in a large storage building, which is typically completely full, in East Grand Forks, Minnesota, U.S., November 22, 2019. Due to a wet summer and early frost, sugar beet farmers were forced to leave hundreds of acres of sugar beet crop unharvested, a hard hit for the US agriculture industry already experiencing a difficult few years. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-SUGAR/
RTX7AOCV
November 27, 2019
Sugar beets covered in snow at a processing facility in East Grand Forks, Minnesota, U.S., November 22,...
EAST GRAND FORKS, UNITED STATES
Frozen harvest leaves bitter taste for US sugar beet farmers
Sugar beets covered in snow at a processing facility in East Grand Forks, Minnesota, U.S., November 22, 2019. Due to a wet summer and early frost, sugar beet farmers were forced to leave hundreds of acres of sugar beet crop unharvested, a hard hit for the US agriculture industry already experiencing a difficult few years. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-SUGAR/
RTX7AOCP
November 27, 2019
Sugar beets covered in snow at a processing facility in East Grand Forks, Minnesota, U.S., November 22,...
EAST GRAND FORKS, UNITED STATES
Frozen harvest leaves bitter taste for US sugar beet farmers
Sugar beets covered in snow at a processing facility in East Grand Forks, Minnesota, U.S., November 22, 2019. Due to a wet summer and early frost, sugar beet farmers were forced to leave hundreds of acres of sugar beet crop unharvested, a hard hit for the US agriculture industry already experiencing a difficult few years. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
CLIMATE-CHANGE/SALTWATER FARMING
RTX7AKYJ
November 26, 2019
Seawater irrigation pipework runs along the ground on an experimental farm on the west coast of Scotland...
AYRESHIRE, United Kingdom
Seawater irrigation pipework runs along the ground on an experimental farm on the west coast of Scotland...
Seawater irrigation pipework runs along the ground on an experimental farm on the west coast of Scotland near Turnberry in Ayreshire, Scotland, Britain November 12, 2019. REUTERS/Stuart McDill
USA-DAILYLIFE/
RTX79COB
November 17, 2019
Crabs are seen at the fish market in Washington, U.S., November 17, 2019. REUTERS/Yara Nardi
Washington, UNITED STATES
Crabs are seen at the fish market
Crabs are seen at the fish market in Washington, U.S., November 17, 2019. REUTERS/Yara Nardi
BELGIUM-BEER/
RTX78PVY
November 13, 2019
Beer bottles are pictured at the traditional Cantillon brewery, the oldest lambic brewery in Brussels,...
Brussels, Belgium
Beer bottles are pictured at the traditional Cantillon brewery in Brussels
Beer bottles are pictured at the traditional Cantillon brewery, the oldest lambic brewery in Brussels, Belgium November 13, 2019. REUTERS/Francois Lenoir
CHINA-DAILYLIFE/
RTX78H65
November 12, 2019
An employee gets pork balls for a customer at a restaurant in Beijing, China, November 12, 2019. REUTERS/Jason...
Beijing, China
An employee gets pork balls for a customer at a restaurant in Beijing
An employee gets pork balls for a customer at a restaurant in Beijing, China, November 12, 2019. REUTERS/Jason Lee
GLOBAL-MEAT/ASF
RTX77UUZ
November 08, 2019
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September...
Buenos Aires, Argentina
Cows are seen in a farm in Azul, in Buenos Aires
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September 30. REUTERS/Agustin Marcarian
GLOBAL-MEAT/ASF
RTX77UUX
November 08, 2019
A cow is seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September...
Buenos Aires, Argentina
A cow is seen in a farm in Azul, in Buenos Aires
A cow is seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September 30. REUTERS/Agustin Marcarian
GLOBAL-MEAT/ASF
RTX77UUW
November 08, 2019
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September...
Buenos Aires, Argentina
Cows are seen in a farm in Azul, in Buenos Aires
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September 30. REUTERS/Agustin Marcarian
GLOBAL-MEAT/ASF
RTX77UUV
November 08, 2019
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September...
Buenos Aires, Argentina
Cows are seen in a farm in Azul, in Buenos Aires
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September 30. REUTERS/Agustin Marcarian
GLOBAL-MEAT/ASF
RTX77UUU
November 08, 2019
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September...
Buenos Aires, Argentina
Cows are seen in a farm in Azul, in Buenos Aires
Cows are seen in a farm in Azul, in Buenos Aires, Argentina September 30, 2019. Picture taken September 30. REUTERS/Agustin Marcarian
Sort by
Display
Items per page
Page
of 71